Inicio › Enfermedades autoinmunes › Nueva York › New York City
Ensayos clínicos de Enfermedades autoinmunes en New York City, NY
19 estudios para Enfermedades autoinmunes buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ReclutandoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ReclutandoFase 3
- Memorial Sloan Kettering Cancer Center, New York
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
ReclutandoFase 2/3
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
Daratumumab in Primary Antiphospholipid Syndrome
ReclutandoFase 1/2
- NYU Langone, New York
- Hospital for Special Surgery, New York
- Weill Cornell, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
ReclutandoFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ReclutandoFase 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
ReclutandoFase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Abatacept for the Treatment of Giant Cell Arteritis
ReclutandoFase 3
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
ReclutandoFase 3
- Icahn School of Medicine at Mount Sinai, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
ReclutandoFase 2/3
- Columbia University Irving Medical Center, New York
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
ReclutandoFase 1/2
- Columbia University, New York
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
ReclutandoFase 3
- Site Number - 1036, New York
- Site Number - 1034, New York
Autoimmune and Autoinflammatory Genetics Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- y 3 más
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
ReclutandoFase 1/2
- Columbia University, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
ReclutandoFase 1
- Montefiore Medical Center, New York
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
ReclutandoFase 1
- Columbia University Irving Medical Center, New York
Biologics And Clinical Immunology Cohort at Sinai
ReclutandoEstudio observacional
- Mount Sinai, New York
Allergy and Immunology Natural History Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Más información sobre Enfermedades autoinmunes en MedlinePlus
Ensayos de Enfermedades autoinmunes en otras ciudades
- Houston, TX21 estudios
- Washington, DC19 estudios
- Philadelphia, PA16 estudios
- Durham, NC15 estudios
- Boston, MA13 estudios
- Chicago, IL12 estudios
- Los Angeles, CA12 estudios
- Dallas, TX9 estudios
- Atlanta, GA8 estudios
- Portland, OR8 estudios
- Milwaukee, WI8 estudios
- Cleveland, OH8 estudios
Otros estudios en New York City
- Cáncer de seno136 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)109 estudios
- Cáncer de próstata103 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario69 estudios
- Cáncer de pulmón60 estudios
- Mieloma múltiple60 estudios
- Cáncer de páncreas60 estudios
- Cáncer de endometrio52 estudios
- Leucemia mielógena aguda51 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.